Meeder Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-720
| Closed | -$3K | – | 2687 |
|
|
2020
Q1 | $3K | Sell |
720
-13,590
| -95% | -$56.6K | ﹤0.01% | 2037 |
|
|
2019
Q4 | $73K | Buy |
14,310
+13,721
| +2,330% | +$70K | ﹤0.01% | 900 |
|
|
2019
Q3 | $3K | Sell |
589
-2,565
| -81% | -$13.1K | ﹤0.01% | 1922 |
|
|
2019
Q2 | $20K | Buy |
3,154
+2,569
| +439% | +$16.3K | ﹤0.01% | 1247 |
|
|
2019
Q1 | $3K | Sell |
585
-790
| -57% | -$4.05K | ﹤0.01% | 1526 |
|
|
2018
Q4 | $6K | Sell |
1,375
-2,806
| -67% | -$12.2K | ﹤0.01% | 1389 |
|
|
2018
Q3 | $26K | Buy |
4,181
+3,584
| +600% | +$22.3K | ﹤0.01% | 965 |
|
|
2018
Q2 | $4.8K | Sell |
597
-232
| -28% | -$1.87K | ﹤0.01% | 1286 |
|
|
2018
Q1 | $6K | Sell |
829
-118
| -12% | -$854 | ﹤0.01% | 1200 |
|
|
2017
Q4 | $6K | Buy |
947
+202
| +27% | +$1.28K | ﹤0.01% | 1291 |
|
|
2017
Q3 | $5K | Buy |
745
+3
| +0.4% | +$20 | ﹤0.01% | 1299 |
|
|
2017
Q2 | $5K | Buy |
742
+265
| +56% | +$1.79K | ﹤0.01% | 1226 |
|
|
2017
Q1 | $5K | Sell |
477
-162
| -25% | -$1.7K | ﹤0.01% | 1122 |
|
|
2016
Q4 | $6K | Buy |
+639
| New | +$6K | ﹤0.01% | 845 |
|